AAAAAA

   
Results: 1-25 |
Results: 25

Authors: KE HZ SHEN VW QI H CRAWFORD DT WU DD LIANG XG CHIDSEYFRINK KL PIRIE CM SIMMONS HA THOMPSON DD
Citation: Hz. Ke et al., PROSTAGLANDIN E-2 INCREASES BONE STRENGTH IN INTACT RATS AND IN OVARIECTOMIZED RATS WITH ESTABLISHED OSTEOPENIA, Bone (New York, N.Y.), 23(3), 1998, pp. 249-255

Authors: SIMMONS HA PIRIE CM THOMPSON DD KE HZ
Citation: Ha. Simmons et al., PARATHYROID-HORMONE-(1-34) INCREASED TOTAL-BODY BONE MASS IN AGED FEMALE RATS, The Journal of pharmacology and experimental therapeutics, 286(1), 1998, pp. 341-344

Authors: ROSATI RL JARDINE PD CAMERON KO THOMPSON DD KE HZ TOLER SM BROWN TA PAN LC EBBINGHAUS CF REINHOLD AR ELLIOTT NC NEWHOUSE BN TJOA CM SWEETNAM PM COLE MJ ARRIOLA MW GAUTHIER JW CRAWFORD DT NICKERSON DF PIRIE CM QI H SIMMONS HA TKALCEVIC GT
Citation: Rl. Rosati et al., DISCOVERY AND PRECLINICAL PHARMACOLOGY OF A NOVEL, POTENT, NONSTEROIDAL ESTROGEN-RECEPTOR AGONIST ANTAGONIST, CP-336156, A DIARYLTETRAHYDRONAPHTHALENE/, Journal of medicinal chemistry, 41(16), 1998, pp. 2928-2931

Authors: KE HZ PARALKAR VM GRASSER WA CRAWFORD DT QI H SIMMONS HA PIRIE CM CHIDSEYFRINK KL OWEN TA SMOCK SL CHEN HK JEE WSS CAMERON KO ROSATI RL BROWN TA DASILVAJARDINE P THOMPSON DD
Citation: Hz. Ke et al., EFFECTS OF CP-336,156, A NEW, NONSTEROIDAL ESTROGEN AGONIST ANTAGONIST, ON BONE, SERUM-CHOLESTEROL, UTERUS, AND BODY-COMPOSITION IN RAT MODELS/, Endocrinology, 139(4), 1998, pp. 2068-2076

Authors: KE HZ CHEN HK SIMMONS HA QI H CRAWFORD DT PIRIE CM CHIDSEYFRINK KL MA YF JEE WSS THOMPSON DD
Citation: Hz. Ke et al., COMPARATIVE EFFECTS OF DROLOXIFENE, TAMOXIFEN, AND ESTROGEN ON BONE, SERUM-CHOLESTEROL, AND UTERINE HISTOLOGY IN THE OVARIECTOMIZED RAT MODEL, Bone, 20(1), 1997, pp. 31-39

Authors: PARALKAR VM GRASSER WA OWEN TA VAIL AL PIRIE CM THOMPSON DD
Citation: Vm. Paralkar et al., 5-FLUOROURACIL TREATMENT OF RAT BONE-MARROW CELLS PRODUCES A POPULATION OF STEM-CELLS THAT CAN RESPOND TO PROSTAGLANDINE(2) (PGE(2)) AND DIFFERENTIATE TO THE OSTEOBLASTIC LINEAGES, Journal of bone and mineral research, 12, 1997, pp. 339-339

Authors: CRAWFORD DT CHIDSEYFRINK KL QI H PIRIE CM KE HZ THOMPSON DD
Citation: Dt. Crawford et al., CP-336,156 PROTECTS AGAINST CANCELLOUS AND CORTICAL BONE LOSS IN OVARIECTOMIZED RATS - A PERIPHERAL QUANTITATIVE COMPUTED-TOMOGRAPHY (PQCT)STUDY, Journal of bone and mineral research, 12, 1997, pp. 488-488

Authors: KE HZ CHIDSEYFRINK KL QI H CRAWFORD DT PIRIE CM SIMMONS HA THOMPSON DD
Citation: Hz. Ke et al., DROLOXIFENE INCREASES BONE MASS IN OVARIECTOMIZED RATS WITH ESTABLISHED OSTEOPENIA, Journal of bone and mineral research, 12, 1997, pp. 494-494

Authors: LIANG XG CRAWFORD DT CHIDSEYFRINK KL PIRIE CM SIMMONS HA THOMPSON DD SHEN V KE HZ
Citation: Xg. Liang et al., PROSTAGLANDIN E-2 INCREASES MECHANICAL STRENGTH OF THE DISTAL FEMUR, FEMORAL-NECK, FEMORAL DIAPHYSIS AND LUMBAR VERTEBRAL BODY IN ADULT MALE-RATS, Journal of bone and mineral research, 12, 1997, pp. 495-495

Authors: GRASSER WA OWEN TA MANSOLF AL PIRIE CM THOMPSON DD PARALKAR VM
Citation: Wa. Grasser et al., 5-FLUOROURACIL TREATMENT OF RAT BONE-MARROW CELLS PRODUCES A POPULATION OF STEM-CELLS THAT CAN DIFFERENTIATE TO THE OSTEOBLASTIC AND OSTEOCLASTIC LINEAGES, Molecular biology of the cell, 7, 1996, pp. 3389-3389

Authors: THOMPSON DD OI H CRAWFORD DT PIRIE CM SIMMONS HA KE HZ
Citation: Dd. Thompson et al., DROLOXIFENE DOES NOT BLUNT THE BONE ANABOLIC EFFECTS OF PROSTAGLANDINE(2) (PGE(2)) BUT MAINTAINS THE PGE(2)-RESTORED BONE IN OSTEOPENIC RATS, Journal of bone and mineral research, 11, 1996, pp. 1-1

Authors: KE HZ CRAWFORD DT OI H CHIDSEYFRINK KL SIMMONS HA PIRIE CM CHEN HK JEE WSS ROSATI RL CAMERON KO TOLER SM JARDINE PD THOMPSON DD
Citation: Hz. Ke et al., CP-336,156, A HIGHLY POTENT ESTROGEN AGONIST ANTAGONIST, PREVENTS BONE LOSS, REDUCES TOTAL SERUM-CHOLESTEROL, BUT LACKS UTERINE STIMULATIVEEFFECT IN OVARIECTOMIZED RATS/, Journal of bone and mineral research, 11, 1996, pp. 251-251

Authors: GRASSER WA MANSOLI AL PIRIE CM CAMERON KO TOLER SM ROSATI RL BROWN TA DASILVAJARDINE P THOMPSON DD PARALKAR VM
Citation: Wa. Grasser et al., CP-336,156 AND ESTROGEN IDENTICALLY INHIBIT OSTEOCLASTOGENESIS IN RATBONE-MARROW CULTURES THROUGH AN APOPTOTIC MECHANISM, Journal of bone and mineral research, 11, 1996, pp. 392-392

Authors: KE HZ CHEN HK QI H PIRIE CM SIMMONS HA MA YF JEE WSS THOMPSON DD
Citation: Hz. Ke et al., EFFECTS OF DROLOXIFENE ON PREVENTION OF CANCELLOUS BONE LOSS AND BONETURNOVER IN THE AXIAL SKELETON OF AGED, OVARIECTOMIZED RATS, Bone, 17(5), 1995, pp. 491-496

Authors: THOMPSON DD SIMMONS HA PIRIE CM KE HZ
Citation: Dd. Thompson et al., FDA GUIDELINES AND ANIMAL-MODELS FOR OSTEOPOROSIS, Bone, 17(4), 1995, pp. 125-133

Authors: CHEN HK ZE HZ LIN CH MA YF QI H CRAWFORD DT PIRIE CM SIMMONS HA JEE WSS THOMPSON DD
Citation: Hk. Chen et al., DROLOXIFENE INHIBITS CORTICAL BONE TURNOVER ASSOCIATED WITH ESTROGEN DEFICIENCY IN RATS, Bone, 17(4), 1995, pp. 175-179

Authors: CHEN HK KE HZ JEE WSS MA YF PIRIE CM SIMMONS HA THOMPSON DD
Citation: Hk. Chen et al., DROLOXIFENE PREVENTS OVARIECTOMY-INDUCED BONE LOSS IN TIBIAE AND FEMORA OF AGED FEMALE RATS - A DUAL-ENERGY X-RAY ABSORPTIOMETRIC AND HISTOMORPHOMETRIC STUDY, Journal of bone and mineral research, 10(8), 1995, pp. 1256-1262

Authors: KE HZ CRAWFORD DT SIMMONS HA PIRIE CM OI H THOMPSON DD
Citation: Hz. Ke et al., COMPARATIVE EFFECTS OF DROLOXIFENE, TAMOXIFEN AND ESTROGEN ON BONE, SERUM-CHOLESTEROL, AND UTERINE HISTOLOGY IN THE OVARIECTOMIZED RAT, Journal of bone and mineral research, 10, 1995, pp. 143-143

Authors: OI H KE HZ CRAWFORD DT PIRIE CM SIMMONS HA THOMPSON DD
Citation: H. Oi et al., DROLOXIFENE PREVENTS CANCELLOUS BONE LOSS AND INHIBITS BONE TURNOVER IN THE FEMORAL-NECK OF OVARIECTOMIZED RATS, Journal of bone and mineral research, 10, 1995, pp. 198-198

Authors: SIMMONS HA PIRIE CM GRASSER WA THOMPSON DD
Citation: Ha. Simmons et al., BONE CELL-DYNAMICS FOLLOWING MARROW ABLATION AND THE ROLE OF PROSTAGLANDINS, Journal of bone and mineral research, 10, 1995, pp. 307-307

Authors: GRASSER WA PAN LC SIMMONS HA SMOCK SL PIRIE CM THOMPSON DD
Citation: Wa. Grasser et al., DROLOXIFENE AND ESTROGEN IDENTICALLY INHIBIT OSTEOCLASTOGENESIS IN RAT BONE-MARROW CULTURES, Journal of bone and mineral research, 10, 1995, pp. 323-323

Authors: CHEN HK KE HZ LIN CH MA YF",OI,"QI H CRAWFORD DT SIMMONS HA PIRIE CM JEE WSS THOMPSON DD
Citation: Hk. Chen et al., DROLOXIFENE INHIBITS CORTICAL BONE TURNOVER ASSOCIATED WITH ESTROGEN DEFICIENCY IN RATS, Journal of bone and mineral research, 10, 1995, pp. 355-355

Authors: KE HZ SIMMONS HA PIRIE CM CRAWFORD DT THOMPSON DD
Citation: Hz. Ke et al., DROLOXIFENE, A NEW ESTROGEN ANTAGONIST AGONIST, PREVENTS BONE LOSS INOVARIECTOMIZED RATS, Endocrinology, 136(6), 1995, pp. 2435-2441

Authors: THOMPSON DD SIMMONS HA PIRIE CM HUDSON G
Citation: Dd. Thompson et al., DIFFERENTIAL RESPONSE OF BONE FROM OVARIECTOMIZED RATS TO VARYING DELIVERY REGIMENS AND DOSES OF ESTROGEN, Journal of bone and mineral research, 8, 1993, pp. 190000272-190000272

Authors: SIMMONS HA KE HZ PIRIE CM THOMPSON DD
Citation: Ha. Simmons et al., RAPID ACTIVATION OF BONE TURNOVER PRODUCES PROGRESSIVE TRABECULAR THINNING AND OSTEOPENIA IN OVARIECTOMIZED RATS, Journal of bone and mineral research, 8, 1993, pp. 190000272-190000272
Risultati: 1-25 |